Progesterone Receptor-negative Breast Cancer Active Not Recruiting Phase 2 Trials for Paclitaxel (DB01229)

IndicationStatusPhase
DBCOND0028547 (Progesterone Receptor-negative Breast Cancer)Active Not Recruiting2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01463072Nab-Paclitaxel in Treating Older Patients With Locally Advanced or Metastatic Breast CancerTreatment